Yongjun Liu

705 total citations
19 papers, 536 citations indexed

About

Yongjun Liu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yongjun Liu has authored 19 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Yongjun Liu's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Yongjun Liu is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Yongjun Liu collaborates with scholars based in China and United States. Yongjun Liu's co-authors include Anhua Wu, Wenlin Tai, Shan Zhu, Xiaoyuan Zhao, Ting Li, Yanni Yang, Zhengkun Li, Tao Zhang, Nihong Lu and Wenjuan Wu and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Yongjun Liu

18 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongjun Liu China 11 400 384 124 53 52 19 536
Yubin Feng China 13 310 0.8× 165 0.4× 62 0.5× 34 0.6× 48 0.9× 27 387
Xiuju Sun China 14 288 0.7× 157 0.4× 98 0.8× 56 1.1× 52 1.0× 24 398
Megan Roche United States 8 256 0.6× 246 0.6× 52 0.4× 100 1.9× 67 1.3× 11 422
Zhengyan Chang China 13 312 0.8× 235 0.6× 47 0.4× 64 1.2× 31 0.6× 24 409
Changfei Yuan China 13 313 0.8× 225 0.6× 112 0.9× 62 1.2× 16 0.3× 22 436
Naoki Hayashi Japan 9 356 0.9× 201 0.5× 39 0.3× 141 2.7× 67 1.3× 12 464
Hai‐Yu Mo China 9 350 0.9× 239 0.6× 71 0.6× 95 1.8× 74 1.4× 13 513
Di Gu China 11 201 0.5× 117 0.3× 189 1.5× 83 1.6× 44 0.8× 37 399

Countries citing papers authored by Yongjun Liu

Since Specialization
Citations

This map shows the geographic impact of Yongjun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Liu more than expected).

Fields of papers citing papers by Yongjun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Liu. The network helps show where Yongjun Liu may publish in the future.

Co-authorship network of co-authors of Yongjun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjun Liu. A scholar is included among the top collaborators of Yongjun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjun Liu. Yongjun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Xuechun, et al.. (2025). CHK1 inhibition overcomes gemcitabine resistance in non-small cell lung cancer cell A549. Molecular & Cellular Oncology. 12(1). 2488537–2488537. 1 indexed citations
2.
3.
Li, Peng, Yiyong Zhu, Xinyu Chen, et al.. (2024). Mechanism of microbial action of the inoculated nitrogen-fixing bacterium for growth promotion and yield enhancement in rice (Oryza sativa L.). PubMed. 2(4). 32–32. 10 indexed citations
4.
Li, Wenxuan, et al.. (2023). Treatment of Rheumatoid Arthritis With Curcumin Analog 3,5-bis(arylidene)-4-piperidone. Future Medicinal Chemistry. 15(22). 2051–2064. 3 indexed citations
5.
Ma, Xuan, et al.. (2023). MiR-17- 5p/RRM2 regulated gemcitabine resistance in lung cancer A549 cells. Cell Cycle. 22(11). 1367–1379. 13 indexed citations
6.
Liu, Yongjun, et al.. (2023). MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway. Cancer Biology & Therapy. 24(1). 2224512–2224512. 6 indexed citations
7.
Wu, Jing, Shan Zhu, Shuang Li, et al.. (2020). A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo. Frontiers in Pharmacology. 11. 8–8. 15 indexed citations
8.
Zhu, Shan, Jing Wu, Yuan Qiao, et al.. (2020). A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation. Frontiers in Cell and Developmental Biology. 8. 262–262. 7 indexed citations
9.
Yang, Yanni, Wenlin Tai, Nihong Lu, et al.. (2020). lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging. 12(10). 9085–9102. 139 indexed citations
10.
Zhang, Bin, et al.. (2019). <p>Screening miRNAs associated with resistance gemcitabine from exosomes in A549 lung cancer cells</p>. Cancer Management and Research. Volume 11. 6311–6321. 14 indexed citations
11.
Sun, Lin, Huimin Chu, Hai Li, & Yongjun Liu. (2019). LncRNA SNHG1 correlates with higher T stage and worse overall survival, and promotes cell proliferation while reduces cell apoptosis in breast cancer. Translational Cancer Research. 8(2). 603–613. 5 indexed citations
12.
Ma, Xuan, et al.. (2019). Research progress on the relationship between lung cancer drug-resistance and microRNAs. Journal of Cancer. 10(27). 6865–6875. 19 indexed citations
13.
Li, Xiang, et al.. (2019). MicroRNA‑124 suppresses cell proliferation and invasion of triple negative breast cancer cells by targeting STAT3. Molecular Medicine Reports. 19(5). 3667–3675. 40 indexed citations
14.
Yang, Ning, et al.. (2018). MicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment. Frontiers in Immunology. 9. 67 indexed citations
15.
16.
Liu, Yongjun, et al.. (2017). Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic B Biointerfaces. Colloids and Surfaces. 1 indexed citations
17.
Sun, Huadong, Yongjun Liu, Juan Chen, et al.. (2017). The pivotal role of HIF-1α in lung inflammatory injury induced by septic mesenteric lymph. Biomedicine & Pharmacotherapy. 91. 476–484. 19 indexed citations
18.
Zhang, Tingting, et al.. (2016). miRNA-10b sponge: An anti-breast cancer study in vitro. Oncology Reports. 35(4). 1950–1958. 45 indexed citations
19.
Liu, Yongjun, et al.. (2013). microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma. PLoS ONE. 8(7). e69478–e69478. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yubin Feng Breakdown of academic impact, for papers by Xiuju Sun Breakdown of academic impact, for papers by Megan Roche Breakdown of academic impact, for papers by Zhengyan Chang Breakdown of academic impact, for papers by Changfei Yuan Breakdown of academic impact, for papers by Naoki Hayashi Breakdown of academic impact, for papers by Hai‐Yu Mo Breakdown of academic impact, for papers by Di Gu
Rankless by CCL
2026